Cantor Fitzgerald’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$211 Buy
+173
New +$708 ﹤0.01% 792

Other funds holding KPTI

Cantor Fitzgerald's KPTI Position: Q3 2026 in Review

Cantor Fitzgerald opened a new position in Karyopharm Therapeutics (KPTI) in Q3 2026: 173 shares worth $211. The stake represents ﹤0.01% of the portfolio and ranks #792 among its holdings.

92 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.

  • Cantor Fitzgerald held 173 shares of Karyopharm Therapeutics worth $211 as of Q3 2026.
  • Karyopharm Therapeutics was a new Cantor Fitzgerald position in Q3 2026.
  • Karyopharm Therapeutics made up ﹤0.01% of Cantor Fitzgerald's portfolio in Q3 2026, its #792 holding.
  • 92 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.

Based on Cantor Fitzgerald's 13F filing for Q3 2026, filed 16 Nov 2026.